Fortress Biotech

FBIOP NASDAQ
21.54
+0.39
+1.86%
Closed 16:00 07/19 EDT
Open
21.13
Prev Close
21.15
High
21.54
Low
21.13
Volume
1.97K
Avg Vol (3M)
4.05K
52 Week High
21.93
52 Week Low
11.90
% Turnover
0.00%
Market Cap
1.40B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Fortress Biotech FBIOP stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
MORE >

Recently

Name
Price
%Change